Stay updated on Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial
Sign up to get notified when there's something new on the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page.

Latest updates to the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page
- ChecktodayChange DetectedRevision label updated from v3.6.3 to v3.6.4. This appears to be a minor update to the page without changes to the study data, eligibility criteria, or results.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision label changed from v3.6.2 to v3.6.3, indicating a small update to the page's documentation or formatting.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page meta. There is no indication that the study content or visible details were altered.SummaryDifference0.1%

- Check44 days agoChange DetectedRecruitment status now shows that the study is no longer recruiting participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions/Treatment heading formatting was standardized, along with a page revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check51 days agoChange DetectedThe page's revision label updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor platform update rather than changes to the study information.SummaryDifference0.1%

- Check59 days agoChange DetectedUpdated study status to Completed with actual enrollment (17) and completion dates (primary: 2023-12-21; study: 2025-09-22). The page now includes the Informed Consent Form as a downloadable document under Study Documents.SummaryDifference2%

Stay in the know with updates to Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccination With Flt3L, Radiation, and Poly-ICLC Clinical Trial page.